Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Asset Writedowns and Impairment (2020 - 2025)

Cytek Biosciences' Asset Writedowns and Impairment history spans 6 years, with the latest figure at -$54000.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 96.26% year-over-year to -$54000.0; the TTM value through Dec 2025 reached $413000.0, up 745.31%, while the annual FY2025 figure was $413000.0, 745.31% up from the prior year.
  • Asset Writedowns and Impairment reached -$54000.0 in Q4 2025 per CTKB's latest filing, down from $132000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.5 million in Q3 2024 to a low of -$1.4 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 5 years is $98000.0, with a median of $132000.0 recorded in 2025.
  • Peak YoY movement for Asset Writedowns and Impairment: skyrocketed 467.24% in 2022, then tumbled 7135.71% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $155000.0 in 2021, then soared by 89.68% to $294000.0 in 2022, then plummeted by 279.93% to -$529000.0 in 2023, then plummeted by 172.59% to -$1.4 million in 2024, then soared by 96.26% to -$54000.0 in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Asset Writedowns and Impairment are -$54000.0 (Q4 2025), $132000.0 (Q3 2025), and $21000.0 (Q2 2025).